Fig. 3From: Efficacy and safety during extended treatment of lesinurad in combination with febuxostat in patients with tophaceous gout: CRYSTAL extension studyProportion of patients with complete resolution of at least one target tophus (a) and percentage mean change from baseline in target tophus area (b) up to 24 months on lesinurad + febuxostat: observed cases. CONT Continuation of lesinurad treatment, CROSS Crossover from core study placebo to lesinurad treatmentBack to article page